Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial

Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial

Abstract Background The aim of the study was to investigate whether intravenous (iv) infusion of exenatide, a synthetic GLP-1 receptor agonist, could provide a protective effect against myocardial ischemia-reperfusion injury after coronary artery bypass graft (CABG) surgery. Methods A sub study anal...

Full description

Bibliographic Details
Main Authors: Guillaume Besch, Andrea Perrotti, Lucie Salomon du Mont, Marc Puyraveau, Xavier Ben-Said, Maude Baltres, Benoit Barrucand, Guillaume Flicoteaux, Lucie Vettoretti, Emmanuel Samain, Sidney Chocron, Sebastien Pili-Floury
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Cardiovascular Diabetology
Subjects:
Coronary artery bypass
Exenatide
Incretins
Glucagon-like peptide 1
Myocardial reperfusion injury
Cardioprotective effects
Online Access:http://link.springer.com/article/10.1186/s12933-018-0784-y

Internet

http://link.springer.com/article/10.1186/s12933-018-0784-y

Similar Items